136 related articles for article (PubMed ID: 11184664)
1. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia.
Overholt BF
Am J Manag Care; 2000 Oct; 6(16 Suppl):S903-8. PubMed ID: 11184664
[TBL] [Abstract][Full Text] [Related]
2. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Panjehpour M; Overholt BF
Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
[TBL] [Abstract][Full Text] [Related]
3. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
7. When to consider endoscopic ablation therapy for Barrett's esophagus.
Shaheen NJ; Frantz DJ
Curr Opin Gastroenterol; 2010 Jul; 26(4):361-6. PubMed ID: 20531183
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
10. New treatments for Barrett's esophagus.
Sampliner RE
Semin Gastrointest Dis; 1997 Apr; 8(2):68-74. PubMed ID: 9109694
[TBL] [Abstract][Full Text] [Related]
11. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends.
Johnston MH
Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):323-30. PubMed ID: 16265286
[TBL] [Abstract][Full Text] [Related]
12. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
Wolfsen HC
Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
[TBL] [Abstract][Full Text] [Related]
13. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
14. [Barrett's esophagus. Update of the endoscopic treatment].
Parquet RA; Sáenz RF
Acta Gastroenterol Latinoam; 2007 Dec; 37(4):250-8. PubMed ID: 18254264
[TBL] [Abstract][Full Text] [Related]
15. New treatment for Barrett's oesophagus.
Barbezat GO
Biomed Pharmacother; 2000 Aug; 54(7):362-7. PubMed ID: 10989974
[TBL] [Abstract][Full Text] [Related]
16. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
17. Laser ablation therapies for Barrett's esophagus.
Abbas G; Pennathur A; Keeley SB; Landreneau RJ; Luketich JD
Semin Thorac Cardiovasc Surg; 2005; 17(4):313-9. PubMed ID: 16428037
[TBL] [Abstract][Full Text] [Related]
18. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends.
Johnston MH
Nat Clin Pract Oncol; 2005 Aug; 2(8):323-30. PubMed ID: 16130939
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.
Panjehpour M; Coppola D; Overholt BF; Vo-Dinh T; Overholt S
Anticancer Res; 2008; 28(1B):485-9. PubMed ID: 18383889
[TBL] [Abstract][Full Text] [Related]
20. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
